Status:
RECRUITING
AI-assisted Diagnosis of Malignant Brain Tumors
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborating Sponsors:
Zhejiang Cancer Hospital
Conditions:
Gliomas
Brain Metastases, Adult
Eligibility:
All Genders
18-100 years
Brief Summary
This study aims to establish a large-scale, multi-center MRI database for malignant brain tumors. It will develop an artificial intelligence system for the segmentation and classification of multiple ...
Detailed Description
This study is mainly based on two centers, the Second Affiliated Hospital of Zhejiang University School of Medicine and the Zhejiang Cancer Hospital. It retrospectively collects cases of malignant bra...
Eligibility Criteria
Inclusion
- Patients diagnosed with glioma, brain metastases, and brain lymphoma by pathology, with the patient being at least 18 years old; preoperative MRI was complete.
Exclusion
- Poor image quality; history of previous brain surgery or radiotherapy; accompanied by other intracranial lesions.
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT07198256
Start Date
September 1 2025
End Date
December 31 2028
Last Update
September 30 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China, 310009
2
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China, 310022